“…We report here results of mRNA expression of genes responsible for key hepatic functions versus culture duration in prolonged cultured human hepatocytes. The hepatocyte-specific genes evaluated include hepatic proteins ALB, TR, and TTR that are generally regarded as markers of mature hepatocytes (Lok and Loh, 1998;Ascoli et al, 2006;Buxbaum et al, 2008;Bal et al, 2013;Fujiwara and Amisaki, 2013;Lee and Wu, 2015;Alemi et al, 2016;Zorzi et al, 2019); the plasma membrane receptor asialoglycoprotein receptor1 (ASGR1) used routinely for the delivery of therapeutic agents specifically to hepatocytes (Merwin et al, 1994;Kim et al, 2005;Thapa et al, 2015;Huang et al, 2017); P450 isoforms CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 that are considered the key isoforms responsible for drug metabolism (Rendic and Guengerich, 2010;Zanger and Schwab, 2013) as well as CYP3A7, a CYP3A isoform mainly expressed in fetal but also expressed in adult livers (Kamataki et al, 1995;Greuet et al, 1996;Okuyama et al, 2020); drug uptake transporters SLC10A1, SLC22A1, SLC22A7, SLCO1B1, SLCO1B3 and SLCO2B1 (Fenner et al, 2012;Barton et al, 2013;Bi et al, 2019), and efflux transporters ABCB1, ABCB11, ABCC2, ABCC3, ABCC4, ABCG2 (Matsushima et al, 2005;Ishiguro et al, 2008;Pfeifer et al, 2014) that play key roles in the regulation of intracellular concentrations of drugs and their metabolites that are transporter substrates. Expression of the housekeeping gene HPRT1 (Nishimura et al, 2006) as a function of culture duration was also evaluated for comparison to the above-mentioned hepatocyte-specific genes.…”